CL Pengajuan SEC - Colgate-Palmolive Company- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

LEI	335800YWKI47DGFKWB26
CIK	21665

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Colgate-Palmolive Company

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

August 1, 2025	EX-99	Colgate-Palmolive Company Announces 2nd Quarter 2025 Results Exhibit 99 Colgate-Palmolive Company Announces 2nd Quarter 2025 Results •Net sales increased 1.
August 1, 2025	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.* EXHIBIT 31-A I, Noel Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the per
August 1, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 1, 2025 (July 31, 2025) COLGA UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 1, 2025 (July 31, 2025) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
August 1, 2025	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.* EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
August 1, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE-PALM
June 25, 2025	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 1-644 A. Full title of the plan an
June 25, 2025	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran
May 30, 2025	EX-1.01	Conflict Minerals Report of Colgate-Palmolive Company, as required by Items 1.01 and 1.02 of this Specialized Disclosure Form (Form SD). Exhibit 1.01 Colgate-Palmolive Company Conflict Minerals Report for the Year Ended December 31, 2024 This Conflict Minerals Report for the year ended December 31, 2024 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 relating to “conflict minerals” (the “Rule”). For purposes of the Rule, “conflict minerals” are limited to cassiterite, columbite-tantalite, wolframite
May 30, 2025	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT COLGATE-PALMOLIVE COMPANY (Exact name of the registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT COLGATE-PALMOLIVE COMPANY (Exact name of the registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 300 Park Avenue, New York, NY 10022 (Address of Principal Executive Offic
May 29, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 29, 2025 COLGATE-PALMOLIVE COMPA UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 29, 2025 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
May 14, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 14, 2025 (May 9, 2025) COLGATE-P UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 14, 2025 (May 9, 2025) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
May 2, 2025	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 2, 2025 (April 28, 2025) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.
May 2, 2025	EX-1.1	Underwriting Agreement, dated April 28, 2025, by and among Colgate-Palmolive Company, Citigroup Global Markets Inc. and Scotia Capital (USA) Inc. Exhibit 1.1 COLGATE-PALMOLIVE COMPANY $500,000,000 4.200% Senior Notes due 2030 Underwriting Agreement April 28, 2025 Citigroup Global Markets Inc. Scotia Capital (USA) Inc. As Representatives of the several Underwriters, c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Scotia Capital (USA) Inc. 250 Vesey Street New York, New York 10281 Ladies and Gentlemen: Colgate-
May 2, 2025	EX-4.2	Form of 4.200% Senior Notes due 2030 Exhibit 4.2 [FACE OF NOTE] THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE REFERRED TO HEREIN. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN S
April 30, 2025	EX-FILING FEES	Table 1: Newly Registered and Carry Forward Securities Calculation of Filing Fee Tables S-3 COLGATE PALMOLIVE CO Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to be Paid 1 Debt 4.
April 30, 2025	424B2	$500,000,000 4.200% Senior Notes due 2030 Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-275201 Prospectus Supplement (To Prospectus dated October 27, 2023) $500,000,000 4.200% Senior Notes due 2030 We are offering $500,000,000 aggregate principal amount of our 4.200% Senior Notes due 2030 (the “Notes”). Interest on the Notes will be payable semi-annually in arrears on May 1 and November 1 of each year, commencing Novembe
April 28, 2025	FWP	$500,000,000 Colgate-Palmolive Company 4.200% Senior Notes due 2030 Final Term Sheet Dated April 28, 2025 Free Writing Prospectus Filed Pursuant to Rule 433 Supplementing Prospectus dated October 27, 2023 and Prospectus Supplement dated April 28, 2025 Registration Statement No.
April 28, 2025	424B2	The information in this preliminary prospectus supplement is not complete and may be changed. The information in this preliminary prospectus supplement is not complete and may be changed.
April 25, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE-PAL
April 25, 2025	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
April 25, 2025	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-A I, Noel Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the per
April 25, 2025	EX-99	Colgate Announces 1st Quarter 2025 Results Exhibit 99 Colgate Announces 1st Quarter 2025 Results •Net sales decreased 3.1%; Organic sales* increased 1.4%, including a 0.4% negative impact from lower private label pet volume; foreign exchange was a 4.4% headwind to net sales •GAAP EPS increased 2% to $0.85; Base Business EPS* increased 6% to $0.91 •GAAP Gross profit margin and Base Business Gross profit margin* increased 80 basis points to
April 25, 2025	EX-10.A	Form of Performance Stock Unit Award Agreement for the 2025-2027 Performance Cycle.* ** EXHIBIT 10-A COLGATE-PALMOLIVE COMPANY 2025 PERFORMANCE STOCK UNIT AWARD NOTICE OF GRANT /$ParticipantName$/ Colgate-Palmolive Company You have been granted an award consisting of the following performance-based Restricted Stock Units (“PBRSUs”) in accordance with the attached 2025 Performance Stock Unit Award Agreement (the “Agreement”): Grant Date: /$GrantDate$/ Target Number of PBRSUs: /$Awards
April 25, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 25, 2025 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
April 24, 2025	PX14A6G	United States Securities and Exchange Commission Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Pursuant to Rule 14a-103 PX14A6G 1 nlpcpx14a6g.htm NATIONAL LEGAL AND POLICY CENTER - PX14A6G United States Securities and Exchange Commission Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Pursuant to Rule 14a-103 Name of the Registrant: Colgate-Palmolive Company Name of persons relying on exemption: National Legal and Policy Center Address of persons relying on exemption: 107 Park Washington Court, Falls Church, V
April 17, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Colgate-Palmolive - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 26, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Colgate-Palmolive Company - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 26, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14
February 13, 2025	EX-97	Colgate-Palmolive Company Dodd-Frank Clawback Policy for the Recovery of Erroneously Awarded Compensation.** EXHIBIT 97 COLGATE-PALMOLIVE COMPANY DODD-FRANK CLAWBACK POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION 1.
February 13, 2025	EX-19	Colgate-Palmolive Company Insider Trading Policy.** EXHIBIT 19 COLGATE-PALMOLIVE COMPANY INSIDER TRADING POLICY Eﬀective Date: December 11, 2024 Purpose This Policy provides guidelines with respect to transactions in the securities of Colgate-Palmolive Company (“Colgate,” and together with Colgate’s direct and indirect subsidiaries, the “Company”).
February 13, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-644 COLGATE-PALMOLIVE
February 13, 2025	EX-24	Powers of Attorney.** EXHIBIT 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS: I, John P. Bilbrey, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Compa
February 13, 2025	EX-21	Subsidiaries of the Registrant.** EXHIBIT 21 COLGATE-PALMOLIVE COMPANY SUBSIDIARIES OF THE REGISTRANT Name of Company Jurisdiction of Organization Cleaning Dimensions, Inc.
February 13, 2025	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to t
February 13, 2025	EX-4.A	Description of Securities of the Registrant** EXHIBIT 4(a) DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of February 13, 2025, Colgate-Palmolive Company, a Delaware corporation (“Colgate” or the “Company”), had five classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) common stock, par value $1.
February 13, 2025	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-A I, Noel Wallace, certify that: 1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
January 31, 2025	EX-99	Colgate Announces 4th Quarter and Full Year 2024 Results Exhibit 99 Colgate Announces 4th Quarter and Full Year 2024 Results Full Year •Delivered over $20 billion in Net sales for the first time •Net sales increased 3.
January 31, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 31, 2025 COLGATE-PALMOLIVE C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 31, 2025 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
January 24, 2025	EX-99.2	Colgate-Palmolive Company Exhibit 99.2 Colgate-Palmolive Company Segment Information (Recast) (Dollars in Millions) (Unaudited) Years Ended December 31, 2023 2022 2021 Net Sales Oral, Personal and Home Care North America(1) $ 4,091 $ 4,002 $ 3,947 Latin America 4,640 3,982 3,663 Europe 2,571 2,362 2,588 Asia Pacific 2,782 2,826 2,867 Africa/Eurasia 1,083 1,082 1,045 Total Oral, Personal and Home Care 15,167 14,254 14,110 P
January 24, 2025	8-K/A	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 25, 2024 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
January 24, 2025	EX-99.1	Colgate Announces 3rd Quarter 2024 Results Exhibit 99.1 Colgate Announces 3rd Quarter 2024 Results •Net sales increased 2.4%; Organic sales* increased 6.8% •GAAP EPS increased 5% to $0.90; Base Business EPS* increased 6% to $0.91 •GAAP Gross profit margin increased 260 basis points to 61.1%; Base Business Gross profit margin* increased 270 basis points to 61.3% •Net cash provided by operations was $2,838 million for the first nine months o
October 25, 2024	EX-99.1	Colgate Announces 3rd Quarter 2024 Results Exhibit 99.1 Colgate Announces 3rd Quarter 2024 Results •Net sales increased 2.4%; Organic sales* increased 6.8% •GAAP EPS increased 5% to $0.90; Base Business EPS* increased 6% to $0.91 •GAAP Gross profit margin increased 260 basis points to 61.1%; Base Business Gross profit margin* increased 270 basis points to 61.3% •Net cash provided by operations was $2,838 million for the first nine months o
October 25, 2024	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
October 25, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE
October 25, 2024	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
October 25, 2024	EX-10.C	Form of Restricted Stock Unit Award Agreement used in connection with grants under the Colgate-Palmolive Company 2019 Incentive Compensation Plan.* ** EXHIBIT 10-C COLGATE-PALMOLIVE COMPANY 2019 INCENTIVE COMPENSATION PLAN RESTRICTED STOCK UNIT NOTICE OF GRANT < > <> <> Colgate-Palmolive Company You have been granted an award consisting of the following Restricted Stock Units (“RSUs”) in accordance with the attached Restricted Stock Unit Award Agreement (the “Agreement”): Grant Date: Number of RSUs Granted: Fair Market Value of Common Stock on G
October 25, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 25, 2024 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
October 25, 2024	EX-99.2	Colgate-Palmolive Company Exhibit 99.2 Colgate-Palmolive Company Segment Information (Recast) (Dollars in Millions) (Unaudited) Years Ended December 31, 2023 2022 2021 Net Sales Oral, Personal and Home Care North America(1) $ 4,091 $ 4,002 $ 3,947 Latin America 4,640 3,982 3,663 Europe 2,571 2,362 2,588 Asia Pacific 2,782 2,826 2,867 Africa/Eurasia 1,083 1,082 1,045 Total Oral, Personal and Home Care 15,167 14,254 14,110 P
October 25, 2024	EX-10.B	Form of Nonqualified Option Award Agreement used in connection with grants under the Colgate-Palmolive Company 2019 Incentive Compensation Plan.* ** EXHIBIT 10-B COLGATE-PALMOLIVE COMPANY 2019 INCENTIVE COMPENSATION PLAN NONQUALIFIED OPTION NOTICE OF GRANT < > <> <> Colgate-Palmolive Company You have been granted an award consisting of the following Options in accordance with the attached Nonqualified Option Award Agreement (the “Agreement”): Grant Date: Number of Options Granted: Option Exercise Price: Vesting Dates: Subject to the terms and
July 26, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 26, 2024 COLGATE-PALMOLIVE COMP UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 26, 2024 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
July 26, 2024	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.* EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
July 26, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE-PALM
July 26, 2024	EX-99	Colgate Announces 2nd Quarter 2024 Results Exhibit 99 Colgate Announces 2nd Quarter 2024 Results •Net sales increased 4.9%; Organic sales* increased 9.0% •GAAP EPS increased 48% to $0.89; Base Business EPS* increased 18% to $0.91 •GAAP Gross profit margin increased 280 basis points to 60.6%; Base Business Gross profit margin* increased 300 basis points to 60.8% •Net cash provided by operations was $1,671 million for the first six months of
July 26, 2024	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
June 25, 2024	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 1-644 A. Full title of the plan an
June 25, 2024	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran
May 31, 2024	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM SD SPECIALIZED DISCLOSURE REPORT COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM SD SPECIALIZED DISCLOSURE REPORT COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
May 31, 2024	EX-1.01	Conflict Minerals Report of Colgate-Palmolive Company, as required by Items 1.01 and 1.02 of this Specialized Disclosure Form (Form SD). Exhibit 1.01 Colgate-Palmolive Company Conflict Minerals Report for the Year Ended December 31, 2023 This Conflict Minerals Report for the year ended December 31, 2023 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 relating to “conflict minerals” (the “Rule”). For purposes of the Rule, “conflict minerals” are limited to cassiterite, columbite-tantalite, wolframite
May 15, 2024	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2024 (May 10, 2024) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
April 26, 2024	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
April 26, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 26, 2024 COLGATE-PALMOLIVE COM UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 26, 2024 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
April 26, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE-PAL
April 26, 2024	EX-99	Colgate Announces 1st Quarter 2024 Results Exhibit 99 Colgate Announces 1st Quarter 2024 Results •Net sales increased 6.2%; Organic sales* increased 9.8% •GAAP EPS increased 84% to $0.83; Base Business EPS* increased 18% to $0.86 •GAAP Gross profit margin and Base Business Gross profit margin* increased 310 basis points to 60.0% •Net cash provided by operations was $681 million for the first three months of 2024 •Colgate’s leadership in to
April 26, 2024	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
April 26, 2024	EX-10	Form of Performance Stock Unit Award Agreement for the 2024-2026 Performance Cycle * ** COLGATE-PALMOLIVE COMPANY 2024 PERFORMANCE STOCK UNIT AWARD NOTICE OF GRANT /$ParticipantName$/ Colgate-Palmolive You have been granted the following performance-based Restricted Stock Units (“PBRSUs”) in accordance with the attached 2024 Performance Stock Unit Award Agreement (the “Agreement”): Grant Date: March 14, 2024 Target Number of PBRSUs: /$AwardsGranted$/ Fair Market Value of Common Stock on Grant Date: $88.
April 18, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin
March 27, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14
March 27, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin
March 27, 2024	DEF 14A	DEFINITIVE PROXY STATEMENT Our Priorities Learn more about our key priorities from the Annual Report, available in the Investors section of our website at www.
February 15, 2024	EX-4	Description of Securities of the Registrant** EXHIBIT 4(a) DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of February 15, 2024, Colgate-Palmolive Company, a Delaware corporation (“Colgate” or the “Company”), had five classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) common stock, par value $1.
February 15, 2024	EX-97	Colgate-Palmolive Company Dodd-Frank Clawback Policy for the Recovery of Erroneously Awarded Compensation.** COLGATE-PALMOLIVE COMPANY DODD-FRANK CLAWBACK POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION 1.
February 15, 2024	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to t
February 15, 2024	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the per
February 15, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 15, 2024 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
February 15, 2024	EX-24	Powers of Attorney.** EXHIBIT 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS: I, John P. Bilbrey, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Compa
February 15, 2024	EX-21	Subsidiaries of the Registrant.** EXHIBIT 21 COLGATE-PALMOLIVE COMPANY SUBSIDIARIES OF THE REGISTRANT Name of Company Jurisdiction of Organization Cleaning Dimensions, Inc.
February 15, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-644 COLGATE-PALMOLIVE
February 13, 2024	SC 13G/A	CL / Colgate-Palmolive Company / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0644-colgatepalmoliveco.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Colgate-Palmolive Co Title of Class of Securities: Common Stock CUSIP Number: 194162103 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to desi
January 26, 2024	EX-99	Colgate Announces 4th Quarter and Full Year 2023 Results Exhibit 99 Colgate Announces 4th Quarter and Full Year 2023 Results 4Q 2023 Net sales and Organic sales both increased 7.
January 26, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 26, 2024 COLGATE-PALMOLIVE C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 26, 2024 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
October 27, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 27, 2023 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
October 27, 2023	EX-24.1	Powers of Attorney Exhibit 24.1 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS: I, John P. Bilbrey, do hereby make, constitute and appoint Noel R. Wallace, Stanley J. Sutula III and Jennifer M. Daniels, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf Registration Statements
October 27, 2023	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
October 27, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE
October 27, 2023	EX-99	Colgate Announces 3rd Quarter 2023 Results Exhibit 99 Colgate Announces 3rd Quarter 2023 Results NEW YORK-(BUSINESS WIRE)-October 27, 2023-Colgate-Palmolive Company (NYSE:CL): Net sales increased 10.
October 27, 2023	EX-10.C	Form of Nonqualified Option Award Agreement used in connection with grants under the Colgate-Palmolive Company 2019 Incentive Compensation Plan. EXHIBIT 10-B COLGATE-PALMOLIVE COMPANY 2019 INCENTIVE COMPENSATION PLAN NONQUALIFIED OPTION NOTICE OF GRANT < > <> <> Colgate-Palmolive Company <> <> You have been granted the following Options in accordance with the attached Nonqualified Option Award Agreement (the “Agreement”): Number of Options Granted: Option Exercise Price: $XX.
October 27, 2023	EX-10.B	Form of Restricted Stock Unit Award Agreement used in connection with grants under the Colgate-Palmolive Company 2019 Incentive Compensation Plan. EXHIBIT 10-C COLGATE-PALMOLIVE COMPANY 2019 INCENTIVE COMPENSATION PLAN RESTRICTED STOCK UNITS NOTICE OF GRANT < > <> <> Colgate-Palmolive Company <> <> You have been granted the following Restricted Stock Units (“RSUs”) in accordance with the attached Restricted Stock Unit Award Agreement (the “Agreement”): Number of RSUs Granted: Fair Market Value of Common Stock on Grant Date: $XX.
October 27, 2023	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
October 27, 2023	EX-FILING FEES	Filing Fee Table Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Colgate-Palmolive Company (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(1) Maximum Aggregate Offering Price(1) Fee Rate(2) Amount of Re
October 27, 2023	S-3ASR	As filed with the Securities and Exchange Commission on October 27, 2023 As filed with the Securities and Exchange Commission on October 27, 2023 Registration No.
October 27, 2023	EX-25.1	Statement of Eligibility on Form T-1 of The Bank of New York Mellon, as Trustee under the Trust Indenture Act of 1939, as amended and with respect to the Indenture, dated as of November 15, 1992 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) ¨ THE BANK OF NEW YORK MELLON (Exact name of trustee as specified in its charter) New York (Jurisdiction
September 15, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 15, 2023 (September 13, 20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 15, 2023 (September 13, 2023) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
September 15, 2023	EX-10.A	Colgate-Palmolive Company Executive Severance Plan, as amended and restated through September 13, 2023 EXHIBIT 10-A September 14, 1989 as amended June 11, 1998; June 14, 2001; June 10, 2004; June 7, 2007; July 8, 2010; September 12, 2013; September 13, 2018; and September 13, 2023 COLGATE-PALMOLIVE COMPANY EXECUTIVE SEVERANCE PLAN, AS AMENDED AND RESTATED 1.
August 18, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 18, 2023 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
July 28, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE-PALM
July 28, 2023	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.* EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
July 28, 2023	EX-99	Colgate Announces 2nd Quarter 2023 Results Exhibit 99 Colgate Announces 2nd Quarter 2023 Results NEW YORK-(BUSINESS WIRE)-July 28, 2023-Colgate-Palmolive Company (NYSE:CL): Net sales increased 7.
July 28, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 28, 2023 COLGATE-PALMOLIVE COMP UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 28, 2023 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
July 28, 2023	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.* EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
June 27, 2023	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran
June 27, 2023	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran
May 26, 2023	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM SD SPECIALIZED DISCLOSURE REPORT COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM SD SPECIALIZED DISCLOSURE REPORT COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
May 26, 2023	EX-1.01	Conflict Minerals Report of Colgate-Palmolive Company, as required by Items 1.01 and 1.02 of this Specialized Disclosure Form (Form SD). Exhibit 1.01 Colgate-Palmolive Company Conflict Minerals Report for the Year Ended December 31, 2022 This Conflict Minerals Report for the year ended December 31, 2022 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 relating to “conflict minerals” (the “Rule”). For purposes of the Rule, “conflict minerals” are limited to cassiterite, columbite-tantalite, wolframite
May 17, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 17, 2023 (May 12, 2023) COLGATE- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 17, 2023 (May 12, 2023) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
April 28, 2023	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
April 28, 2023	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
April 28, 2023	EX-99	Colgate Announces 1st Quarter 2023 Results Exhibit 99 Colgate Announces 1st Quarter 2023 Results NEW YORK-(BUSINESS WIRE)-April 28, 2023-Colgate-Palmolive Company (NYSE:CL): Net sales increased 8.
April 28, 2023	EX-10	Form of Performance Stock Unit Award Agreement for the 2023-2025 Performance Cycle (Registrant hereby incorporates by reference Exhibit 10-A to its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, File No. 1-644.)* COLGATE-PALMOLIVE COMPANY 2023 PERFORMANCE STOCK UNIT AWARD NOTICE OF GRANT /$ParticipantName$/ Colgate-Palmolive You have been granted the following performance-based Restricted Stock Units (“PBRSUs”) in accordance with the attached 2023 Performance Stock Unit Award Agreement (the “Agreement”): Date of Grant: /$GrantDate$/ Target Number of PBRSUs: /$AwardsGranted$/ Fair Market Value of Common Sto
April 28, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 28, 2023 COLGATE-PALMOLIVE COM UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 28, 2023 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
April 28, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE-PAL
April 20, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin
March 29, 2023	DEF 14A	DEFINITIVE PROXY STATEMENT Our Priorities Learn more about our key priorities from the Annual Report, available in the Investors section of our website at www.
March 29, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14
March 29, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin
March 1, 2023	EX-4.2	Form of 4.800% Senior Notes due 2026 Exhibit 4.2 [FACE OF NOTE] THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE REFERRED TO HEREIN. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN S
March 1, 2023	EX-1.1	Underwriting Agreement, dated February 27, 2023, by and among Colgate-Palmolive Company, BNP Paribas Securities Corp., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC. Exhibit 1.1 COLGATE-PALMOLIVE COMPANY $500,000,000 4.800% Senior Notes due 2026 $500,000,000 4.600% Senior Notes due 2028 $500,000,000 4.600% Senior Notes due 2033 Underwriting Agreement February 27, 2023 BNP Paribas Securities Corp. Goldman Sachs & Co. LLC Morgan Stanley & Co. LLC Wells Fargo Securities, LLC As Representatives of the several Underwriters, c/o BNP Paribas Securities Corp. 787 Seve
March 1, 2023	EX-FILING FEES	Calculation of Filing Fee Tables 424(b)(2) (Form Type) Colgate-Palmolive Company (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities EX-FILING FEES 4 c105513ex107.htm Exhibit 107 Calculation of Filing Fee Tables 424(b)(2) (Form Type) Colgate-Palmolive Company (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Pric
March 1, 2023	EX-4.3	Form of 4.600% Senior Notes due 2028 Exhibit 4.3 [FACE OF NOTE] THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE REFERRED TO HEREIN. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN S
March 1, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 1, 2023 (February 27, 2023) CO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 1, 2023 (February 27, 2023) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.
March 1, 2023	EX-4.4	Form of 4.600% Senior Notes due 2033 Exhibit 4.4 [FACE OF NOTE] THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE REFERRED TO HEREIN. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN S
March 1, 2023	424B2	$1,500,000,000 $500,000,000 4.800% Senior Notes due 2026 $500,000,000 4.600% Senior Notes due 2028 $500,000,000 4.600% Senior Notes due 2033 3B2 EDGAR HTML - c105513preflight.htm Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-249768 Prospectus Supplement (To Prospectus dated October 30, 2020) $1,500,000,000 $500,000,000 4.800% Senior Notes due 2026 $500,000,000 4.600% Senior Notes due 2028 $500,000,000 4.600% Senior Notes due 2033 We are offering $500,000,000 aggregate principal amount of our 4.800% Senior Notes due 20
February 27, 2023	FWP	$1,500,000,000 Colgate-Palmolive Company $500,000,000 4.800% Senior Notes due 2026 $500,000,000 4.600% Senior Notes due 2028 $500,000,000 4.600% Senior Notes due 2033 Final Term Sheet Dated February 27, 2023 Free Writing Prospectus Filed Pursuant to Rule 433 Supplementing Prospectus dated October 30, 2020 and Prospectus Supplement dated February 27, 2023 Registration Statement No.
February 27, 2023	424B2	Subject to Completion Preliminary Prospectus Supplement dated February 27, 2023 3B2 EDGAR HTML - c105513preflight.htm The information in this preliminary prospectus supplement is not complete and may be changed. Subject to Completion Preliminary Prospectus Supplement dated February 27, 2023 Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-249768 Preliminary Prospectus Supplement (To Prospectus dated October 30, 2020) $ $ % Senior Notes due $ % Senior Notes due
February 16, 2023	EX-10.I	Amended and Restated Five Year Credit Agreement, dated as of November 4, 2022, by and among Colgate-Palmolive Company, as Borrower, Citibank, N.A., as Administrative Agent and Arranger, and the Lenders party thereto. EXECUTION COPY AMENDED AND RESTATED FIVE YEAR CREDIT AGREEMENT Dated as of November 4, 2022 Among COLGATE-PALMOLIVE COMPANY as Borrower THE BANKS NAMED HEREIN as Banks BANK OF AMERICA, N.
February 16, 2023	EX-24	Powers of Attorney.** EXHIBIT 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS: I, John P. Bilbrey, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Compa
February 16, 2023	EX-21	Subsidiaries of the Registrant.** EXHIBIT 21 COLGATE-PALMOLIVE COMPANY SUBSIDIARIES OF THE REGISTRANT Name of Company Jurisdiction of Organization 887357 Ontario Inc.
February 16, 2023	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the per
February 16, 2023	EX-4.A	Description of Securities of the Registrant** EXHIBIT 4(a) DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of February 16, 2023, Colgate-Palmolive Company, a Delaware corporation (“Colgate” or the “Company”), had five classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) common stock, par value $1.
February 16, 2023	EX-10.J	Colgate-Palmolive Company Supplemental Savings and Investment Plan, amended and restated, effective as of January 1, 202 EXHIBIT 10-J COLGATE-PALMOLIVE COMPANY SUPPLEMENTAL SAVINGS AND INVESTMENT PLAN Amended and Restated Effective as of January 1, 2022 EXHIBIT 10-J TABLE OF CONTENTS PAGE ARTICLE 1.
February 16, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-644 COLGATE-PALMOLIVE
February 16, 2023	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to t
February 9, 2023	SC 13G/A	CL / Colgate-Palmolive Company / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Colgate-Palmolive Co. Title of Class of Securities: Common Stock CUSIP Number: 194162103 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed
January 30, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 30, 2023 (January 30, 2023) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
January 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 27, 2023 COLGATE-PALMOLIVE C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 27, 2023 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
January 27, 2023	EX-99	Colgate Announces 4th Quarter and Full Year 2022 Results Exhibit 99 Colgate Announces 4th Quarter and Full Year 2022 Results 4Q 2022 Net sales increased 5.
January 12, 2023	EX-3.01	Colgate-Palmolive Company By-laws, Amended and Restated as of January 12, 2023. (Registrant hereby incorporates by reference Exhibit 3.01 to its Current Report on Form 8-K filed on January 12, 2023, File No. 1-644.) Exhibit 3.01 January 12, 2023 COLGATE-PALMOLIVE COMPANY AMENDED AND RESTATED BY-LAWS OFFICES 1. The registered office shall be in the City of Wilmington, County of New Castle, State of Delaware, and the name of the registered agent in charge thereof is THE CORPORATION TRUST COMPANY. The corporation may also have offices at such other places within or without the State of Delaware as the board of d
January 12, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 12, 2023 COLGATE-PALMOLIVE C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 12, 2023 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
October 28, 2022	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.* EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
October 28, 2022	EX-99	Colgate Announces 3rd Quarter 2022 Results Exhibit 99 Colgate Announces 3rd Quarter 2022 Results NEW YORK-(BUSINESS WIRE)-October 28, 2022-Colgate-Palmolive Company (NYSE:CL): Net sales increased 1.
October 28, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE
October 28, 2022	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
October 28, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 28, 2022 COLGATE-PALMOLIVE C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 28, 2022 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
August 9, 2022	EX-4.4	Form of 3.250% Senior Notes due 2032 Exhibit 4.4 [FACE OF NOTE] THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE REFERRED TO HEREIN. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (?DTC?), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN S
August 9, 2022	EX-4.2	Form of 3.100% Senior Notes due 2025 Exhibit 4.2 [FACE OF NOTE] THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE REFERRED TO HEREIN. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (?DTC?), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN S
August 9, 2022	EX-4.3	Form of 3.100% Senior Notes due 2027 Exhibit 4.3 [FACE OF NOTE] THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE REFERRED TO HEREIN. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (?DTC?), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN S
August 9, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 9, 2022 (August 9, 2022) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.
August 3, 2022	424B2	$1,500,000,000 $500,000,000 3.100% Senior Notes due 2025 $500,000,000 3.100% Senior Notes due 2027 $500,000,000 3.250% Senior Notes due 2032 424B2 1 c103901424b2.htm Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-249768 Prospectus Supplement (To Prospectus dated October 30, 2020) $1,500,000,000 $500,000,000 3.100% Senior Notes due 2025 $500,000,000 3.100% Senior Notes due 2027 $500,000,000 3.250% Senior Notes due 2032 We are offering $500,000,000 aggregate principal amount of our 3.100% Senior Notes due 2025 (the “2025
August 3, 2022	EX-FILING FEES	Calculation of Filing Fee Tables (Form Type) Colgate-Palmolive Company (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Exhibit 107 Calculation of Filing Fee Tables 424(b)(2) (Form Type) Colgate-Palmolive Company (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to Be Paid Debt 3.
August 3, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 2, 2022 (August 1, 2022) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.
August 3, 2022	EX-1.1	Underwriting Agreement, dated August 1, 2022, by and among Colgate-Palmolive Company, Barclays Capital Inc., BofA Securities, Inc., HSBC Securities (USA) Inc., J.P. Morgan Securities LLC and U.S. Bancorp Investments, Inc. Exhibit 1.1 COLGATE-PALMOLIVE COMPANY $500,000,000 3.100% Senior Notes due 2025 $500,000,000 3.100% Senior Notes due 2027 $500,000,000 3.250% Senior Notes due 2032 Underwriting Agreement August 1, 2022 Barclays Capital Inc. BofA Securities, Inc. HSBC Securities (USA) Inc. J.P. Morgan Securities LLC U.S. Bancorp Investments, Inc. As Representatives of the several Underwriters, c/o Barclays Capital
August 1, 2022	FWP	$1,500,000,000 Colgate-Palmolive Company $500,000,000 3.100% Senior Notes due 2025 $500,000,000 3.100% Senior Notes due 2027 $500,000,000 3.250% Senior Notes due 2032 Final Term Sheet FWP 1 c103901fwp.htm Dated August 1, 2022 Free Writing Prospectus Filed Pursuant to Rule 433 Supplementing Prospectus dated October 30, 2020 and Prospectus Supplement dated August 1, 2022 Registration Statement No. 333-249768 $1,500,000,000 Colgate-Palmolive Company $500,000,000 3.100% Senior Notes due 2025 $500,000,000 3.100% Senior Notes due 2027 $500,000,000 3.250% Senior Notes due 2032 Final T
August 1, 2022	424B2	The information in this preliminary prospectus supplement is not complete and may be changed. Subject to Completion Preliminary Prospectus Supplement dated August 1, 2022 The information in this preliminary prospectus supplement is not complete and may be changed.
July 29, 2022	EX-99	Colgate Announces 2nd Quarter 2022 Results Exhibit 99 Colgate Announces 2nd Quarter 2022 Results NEW YORK-(BUSINESS WIRE)-July 29, 2022-Colgate-Palmolive Company (NYSE:CL): Net sales increased 5.
July 29, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 29, 2022 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
July 29, 2022	EX-10	Colgate-Palmolive Company Executive Officer Cash Severance Policy (registrant hereby incorporates by reference Exhibit 10.1 to its Current Report on Form 8-K filed on April 11, 2022, File No. 1-644). * Exhibit 10.A COLGATE-PALMOLIVE COMPANY EXECUTIVE OFFICER CASH SEVERANCE POLICY Colgate-Palmolive Company (the ?Company?) will not execute any new severance agreement with an executive officer that provides for Cash Severance Benefits exceeding 2.99 times the sum of the executive officer?s base salary plus target annual bonus opportunity, without seeking stockholder ratification of the agreement. ?
July 29, 2022	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
July 29, 2022	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
July 29, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE-PALM
June 28, 2022	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran
June 28, 2022	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 11-K 1 cl11-k2021.htm 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHAN
June 13, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 13, 2022 (June 9, 2022) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
May 31, 2022	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT COLGATE-PALMOLIVE COMPANY (Exact name of the registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT COLGATE-PALMOLIVE COMPANY (Exact name of the registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 300 Park Avenue, New York, NY 10022 (Address of Principal Executive Offic
May 31, 2022	EX-1.01	Conflict Minerals Report of Colgate-Palmolive Company, as required by Items 1.01 and 1.02 of this Specialized Disclosure Form (Form SD). Exhibit 1.01 Colgate-Palmolive Company Conflict Minerals Report for the Year Ended December 31, 2021 This Conflict Minerals Report for the year ended December 31, 2021 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 relating to ?conflict minerals? (the ?Rule?). For purposes of the Rule, ?conflict minerals? are limited to cassiterite, columbite-tantalite, wolframite
May 11, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 11, 2022 (May 6, 2022) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
April 29, 2022	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
April 29, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE-PAL
April 29, 2022	EX-10.A	Form of Performance Stock Unit Award Agreement for the 2021-2023 Performance Cycle (Registrant hereby incorporates by reference Exhibit 10-A to its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, File No. 1-644.)* EXHIBIT 10-A COLGATE-PALMOLIVE COMPANY 2021 PERFORMANCE STOCK UNIT AWARD NOTICE OF GRANT /$TitleCode$/ /$ParticipantName$/ Colgate-Palmolive You have been granted the following performance-based Restricted Stock Units (?PBRSUs?) in accordance with the attached 2021 Performance Stock Unit Award Agreement (the ?Agreement?): Date of Grant: /$GrantDate$/ Target Number of PBRSUs: /$AwardsGranted$/ Fair
April 29, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 29, 2022 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
April 29, 2022	EX-99	Colgate Announces 1st Quarter 2022 Results Exhibit 99 Colgate Announces 1st Quarter 2022 Results NEW YORK-(BUSINESS WIRE)-April 29, 2022-Colgate-Palmolive Company (NYSE:CL): Net sales increased 1.
April 29, 2022	EX-10.B	Form of Performance Stock Unit Award Agreement for the 2022-2024 Performance Cycle (Registrant hereby incorporates by reference Exhibit 10-B to its Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, File No. 1-644.)* EXHIBIT 10-B COLGATE-PALMOLIVE COMPANY 2022 PERFORMANCE STOCK UNIT AWARD NOTICE OF GRANT /$TitleCode$/ /$ParticipantName$/ Colgate-Palmolive You have been granted the following performance-based Restricted Stock Units (?PBRSUs?) in accordance with the attached 2022 Performance Stock Unit Award Agreement (the ?Agreement?): Date of Grant: March 10, 2022 Target Number of PBRSUs: /$AwardsGranted$/ Fair Market Value of Common Stock on Grant Date: $73.
April 29, 2022	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
April 14, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEFA14A 1 cl3983811-defa14a.htm DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confid
April 11, 2022	EX-10.1	Colgate-Palmolive Company Executive Officer Cash Severance Policy. (registrant hereby incorporates by reference Exhibit 10.1 to its Current Report on Form 8-K filed on April 11, 2022, File No 1-644.)* Exhibit 10.1 COLGATE-PALMOLIVE COMPANY EXECUTIVE OFFICER CASH SEVERANCE POLICY Colgate-Palmolive Company (the ?Company?) will not execute any new severance agreement with an executive officer that provides for Cash Severance Benefits exceeding 2.99 times the sum of the executive officer?s base salary plus target annual bonus opportunity, without seeking stockholder ratification of the agreement. ?
April 11, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 8, 2022 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
April 11, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Prox
March 23, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEF 14A 1 cl3983811-def14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidentia
March 23, 2022	DEF 14A	DEFINITIVE PROXY STATEMENT
March 23, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? Filed by the Registrant ? Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
February 17, 2022	EX-24	Powers of Attorney.** EXHIBIT 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS: I, John P. Bilbrey, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Compa
February 17, 2022	EX-21	Subsidiaries of the Registrant.** EXHIBIT 21 COLGATE-PALMOLIVE COMPANY SUBSIDIARIES OF THE REGISTRANT Name of Company Jurisdiction of Organization 887357 Ontario Inc.
February 17, 2022	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to t
February 17, 2022	EX-10.D	Colgate-Palmolive Company Supplemental Salaried Employees’ Retirement Plan, amended and restated, effective as of January 1, 2021. (Registrant hereby incorporates by reference Exhibit 10-D to its Annual Report on Form 10-K for the year ended December 31, 2021, File No. 1-644.)* EXHIBIT 10-D COLGATE-PALMOLIVE COMPANY SUPPLEMENTAL SALARIED EMPLOYEES? RETIREMENT PLAN TABLE OF CONTENTS PAGE ARTICLE 1.
February 17, 2022	EX-10.K	Colgate-Palmolive Company Supplemental Savings and Investment Plan, amended and restated, effective as of January 1, 2021.* ** EXHIBIT 10-K COLGATE-PALMOLIVE COMPANY SUPPLEMENTAL SAVINGS AND INVESTMENT PLAN Effective as of January 1, 2021 TABLE OF CONTENTS PAGE ARTICLE 1.
February 17, 2022	EX-4.A	Description of Securities of the Registrant** EXHIBIT 4(a) DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of February 17, 2022, Colgate-Palmolive Company, a Delaware corporation (?Colgate? or the ?Company?), had five classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): (i) common stock, par value $1.
February 17, 2022	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the per
February 17, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-644 COLGATE-PALMOLIVE
February 9, 2022	SC 13G/A	CL / Colgate-Palmolive Company / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0629-colgatepalmoliveco.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Colgate-Palmolive Co. Title of Class of Securities: Common Stock CUSIP Number: 194162103 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to desi
January 28, 2022	8-K	Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 28, 2022 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
January 28, 2022	EX-99	Colgate Announces 4th Quarter and Full Year 2021 Results Exhibit 99 Colgate Announces 4th Quarter and Full Year 2021 Results Full Year 2021 Net sales increased 6.
December 9, 2021	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 9, 2021 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
December 9, 2021	EX-3.01	Colgate-Palmolive Company By-Laws, Amended and Restated as of December 9, 2021 Exhibit 3.01 December 9, 2021 COLGATE-PALMOLIVE COMPANY AMENDED AND RESTATED BY-LAWS OFFICES 1. The registered office shall be in the City of Wilmington, County of New Castle, State of Delaware, and the name of the registered agent in charge thereof is THE CORPORATION TRUST COMPANY. The corporation may also have offices at such other places within or without the State of Delaware as the board of d
November 12, 2021	EX-99.25	EX-99.25 NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on November 23, 2021, pursuant to the provisions of Rule 12d2-2 (a).
November 10, 2021	8-A12B	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 COLGATE-PALMOLIVE COMPANY (Exact name of regist UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 13-1815595 (State of incorporation or organization) (IRS Employer Identification No.) 300 Park Avenue, New
November 10, 2021	EX-4.2	Form of 0.300% Senior Note due 2029 (incorporated herein by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on November 10, 2021, File No. 1-644) Exhibit 4.2 [FACE OF NOTE] THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE REFERRED TO HEREIN. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF EUROCLEAR BANK, SA/NV, AS OPERATOR OF THE EUROCLEAR SYSTEM (?EUROCLEAR?) AND CLEARSTREAM BANKING, S.A. (?CLEARSTREAM? AND, TOGETHER WITH EUROCLEAR, ?EUROCLEAR/CLEARSTREAM?), TO THE ISSUER OR ITS AGENT FOR REGISTRAT
November 10, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 10, 2021 (November 10, 2021) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.
November 5, 2021	EX-1.1	Underwriting Agreement, dated November 3, 2021, by and among Colgate-Palmolive Company, Citigroup Global Markets Limited and Banco Bilbao Vizcaya Argentaria, S.A. Exhibit 1.1 COLGATE-PALMOLIVE COMPANY ?500,000,000 0.300% Senior Notes due 2029 Underwriting Agreement November 3, 2021 Citigroup Global Markets Limited Banco Bilbao Vizcaya Argentaria, S.A. As Representatives of the several Underwriters, c/o Citigroup Global Markets Limited Citigroup Centre Canada Square, Canary Wharf London E14 5LB United Kingdom Banco Bilbao Vizcaya Argentaria, S.A. Ciudad BBVA
November 5, 2021	424B2	CALCULATION OF REGISTRATION FEE CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to Be Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Amount of Registration Fee (1) 0.
November 5, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 5, 2021 (November 3, 2021) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.
November 3, 2021	424B2	The information in this preliminary prospectus supplement is not complete and may be changed. Subject to Completion Preliminary Prospectus Supplement dated November 3, 2021 The information in this preliminary prospectus supplement is not complete and may be changed.
November 3, 2021	FWP	€500,000,000 Colgate-Palmolive Company 0.300% Senior Notes due 2029 Final Term Sheet Dated November 3, 2021 Free Writing Prospectus Filed Pursuant to Rule 433 Supplementing Prospectus dated October 30, 2020 and Prospectus Supplement dated November 3, 2021 Registration Statement No.
October 29, 2021	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
October 29, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 29, 2021 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
October 29, 2021	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934. EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
October 29, 2021	EX-10.B	Colgate-Palmolive Company Deferred Compensation Plan, amended and restated, effective as of October 28, 2021. (Registrant hereby incorporates by reference Exhibit 10-B to its Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, File No. 1-644.)* EXHIBIT 10-B COLGATE-PALMOLIVE COMPANY DEFERRED COMPENSATION PLAN Colgate-Palmolive Company (the ?Company?) maintains the Deferred Compensation Plan, a non-qualified, unfunded plan (the ?Plan?) for the exclusive benefit of key management and top executive employees of the Company and designated subsidiaries.
October 29, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE
October 29, 2021	EX-99	Colgate Announces 3rd Quarter 2021 Results Exhibit 99 Colgate Announces 3rd Quarter 2021 Results NEW YORK-(BUSINESS WIRE)-October 29, 2021-Colgate-Palmolive Company (NYSE:CL): Net sales increased 6.
October 29, 2021	EX-10.A	, by and among Colgate-Palmolive Company, as Borrower, Citibank, N.A., as Administrative Agent and Arranger, and the Lenders party thereto.(Registrant hereby incorporates by reference Exhibit 10- EXHIBIT 10-A EXECUTION COPY FIVE YEAR CREDIT AGREEMENT Dated as of August 20, 2021 Among COLGATE-PALMOLIVE COMPANY as Borrower THE BANKS NAMED HEREIN as Banks BANK OF AMERICA, N.
July 30, 2021	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.* EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
July 30, 2021	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.* EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
July 30, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) (July 30, 2021) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
July 30, 2021	EX-99	Colgate Announces 2nd Quarter 2021 Results EX-99 2 a52468381ex99.htm EXHIBIT 99 Exhibit 99 Colgate Announces 2nd Quarter 2021 Results NEW YORK-(BUSINESS WIRE)-July 30, 2021-Colgate-Palmolive Company (NYSE:CL): Net sales increased 9.5%, Organic sales* increased 5.0% On a GAAP basis, EPS grew 12% to $0.83; On a Base Business basis, EPS* grew 8% to $0.80 GAAP Gross profit margin and Base Business Gross profit margin* decreased 80 basis points
July 30, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE-PALM
July 22, 2021	EX-99	Colgate Recommends Shareholders Reject “Mini-Tender” Offer By TRC Capital Investment Corporation EX-99 2 a52464755ex99.htm EXHIBIT 99 Exhibit 99 Colgate Recommends Shareholders Reject “Mini-Tender” Offer By TRC Capital Investment Corporation NEW YORK-(BUSINESS WIRE)-July 22, 2021-Colgate-Palmolive Company (“Colgate”) has received notification of an unsolicited “mini-tender” offer by TRC Capital Investment Corporation (“TRC”) to purchase up to 1.5 million shares, or approximately 0.18% of the
July 22, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) (July 22, 2021) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
June 25, 2021	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran
June 25, 2021	11-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran
June 10, 2021	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 9, 2021 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
June 1, 2021	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT COLGATE-PALMOLIVE COMPANY (Exact name of the registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT COLGATE-PALMOLIVE COMPANY (Exact name of the registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 300 Park Avenue, New York, NY 10022 (Address of Principal Executive Offic
June 1, 2021	EX-1.01	Conflict Minerals Report of Colgate-Palmolive Company, as required by Items 1.01 and 1.02 of this Specialized Disclosure Form (Form SD). Exhibit 1.01 Colgate-Palmolive Company Conflict Minerals Report for the Year Ended December 31, 2020 This Conflict Minerals Report for the year ended December 31, 2020 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 relating to ?conflict minerals? (the ?Rule?). For purposes of the Rule, ?conflict minerals? are limited to cassiterite, columbite-tantalite, wolframite
May 13, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 13, 2021 (May 7, 2021) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
April 30, 2021	8-K/A	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 30, 2021 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
April 30, 2021	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.* EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t
April 30, 2021	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.* EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Quarterly Report on Form 10-Q of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
April 30, 2021	EX-99	Colgate Announces 1st Quarter 2021 Results EX-99 2 a1q2021pressreleasetables-.htm EX-99 Exhibit 99 John Faucher 212-310-3653 Hope Spiller 212-310-2291 Colgate Announces 1st Quarter 2021 Results •Net sales increased 6.0%, Organic sales* increased 5.0% •On a GAAP basis, EPS declined 4% to $0.80; On a Base Business basis, EPS* grew 7% to $0.80 •GAAP Gross profit margin increased 50 basis points to 60.7%; Base Business Gross profit margin* inc
April 30, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-644 COLGATE-PAL
April 30, 2021	EX-99	Colgate Announces 1st Quarter 2021 Results Exhibit 99 Colgate Announces 1st Quarter 2021 Results NEW YORK-(BUSINESS WIRE)-April 30, 2021-Colgate-Palmolive Company (NYSE:CL): Net sales increased 6.
April 30, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) (April 30, 2021) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
April 15, 2021	DEFA14A	- DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? Filed by the Registrant ? Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
March 24, 2021	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? Filed by the Registrant ? Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14
March 24, 2021	DEFA14A	- DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS DEFA14A 1 cl3838841-defa14a.htm DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confid
March 24, 2021	DEF 14A	DEFINITIVE PROXY STATEMENT Our Priorities Learn more about our key priorities from the Annual Report, available in the Investors section of our website at www.
March 11, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) (March 11, 2021) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
February 18, 2021	EX-10.L(B)	Amendment 4Q2020-I, dated December 2, 2020, to the Colgate-Palmolive Company Supplemental Savings and Investment Plan* ** EXHIBIT 10-L (b) AMENDMENT 4Q2020-I COLGATE-PALMOLIVE COMPANY SUPPLEMENTAL SAVINGS AND INVESTMENT PLAN WHEREAS, Colgate-Palmolive Company (the ?Company?) maintains the Colgate-Palmolive Company Supplemental Savings and Investment Plan (the ?Plan?) for the benefit of eligible employees of the Company and certain designated affiliated companies; WHEREAS on December 10, 2015, the Board of Directors o
February 18, 2021	EX-4.A	Description of Securities of the Registrant** EXHIBIT 4(a) DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of February 18, 2021, Colgate-Palmolive Company, a Delaware corporation (?Colgate? or the ?Company?), had five classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): (i) common stock, par value $1.
February 18, 2021	EX-31.A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-A I, Noel R. Wallace, certify that: 1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the per
February 18, 2021	EX-10.D(B)	Amendment 4Q2020-I, dated December 2, 2020, to the Colgate-Palmolive Company Supplemental Salaried Employees’ Retirement Plan* EXHIBIT 10-D (b) AMENDMENT 4Q2020-I COLGATE-PALMOLIVE COMPANY SUPPLEMENTAL SALARIED EMPLOYEES? RETIREMENT PLAN WHEREAS, Colgate-Palmolive Company (the ?Company?) maintains the Colgate-Palmolive Company Supplemental Salaried Employees? Retirement Plan (the ?Plan?) for the benefit of eligible employees of the Company and certain designated affiliated companies; WHEREAS on December 10, 2015, the Boar
February 18, 2021	EX-21	Subsidiaries of the Registrant.** EXHIBIT 21 COLGATE-PALMOLIVE COMPANY SUBSIDIARIES OF THE REGISTRANT Name of Company Jurisdiction of Organization 887357 Ontario Inc.
February 18, 2021	EX-31.B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.** EXHIBIT 31-B I, Stanley J. Sutula III, certify that: 1.I have reviewed this Annual Report on Form 10-K of Colgate-Palmolive Company; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to t
February 18, 2021	EX-24	Powers of Attorney.** EXHIBIT 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS: I, John P. Bilbrey, do hereby make, constitute and appoint Jennifer M. Daniels and Kristine Hutchinson, and each of them, as my attorneys-in-fact and agents with full power of substitution for me and in my name, place and stead, in any and all capacities, to execute for me and on my behalf the Annual Report of Colgate-Palmolive Compa
February 18, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-644 COLGATE-PALMOLIVE
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Colgate-Palmolive Co. Title of Class of Securities: Common Stock CUSIP Number: 194162103 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
January 29, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 29, 2021 COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.
January 29, 2021	EX-99	Colgate Announces 4th Quarter 2020 Results Exhibit 99 Colgate Announces 4th Quarter 2020 Results NEW YORK-(BUSINESS WIRE)-January 29, 2021-Colgate-Palmolive Company (NYSE:CL) Net sales increased 7.
November 18, 2020	8-K	Regulation FD Disclosure - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 18, 2020 COLGATE-PALMOLIVE COMPANY (Exact Name of Registrant as Specified in Charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
October 30, 2020	EX-10.1	Separation Agreement between Henning Jakobsen and Colgate-Palmolive Company Exhibit 10.1 October 13, 2020 Henning Jakobsen Dear Henning: This letter of agreement and general release (“Agreement”) confirms our mutual agreement regarding the terms and conditions of your separation from employment with Colgate-Palmolive Company, its parent, and each of their subsidiaries and affiliates (“Colgate” or the “Company”). You and the Company agree as follows: 1. Employment. Your la
October 30, 2020	S-3ASR	- 3B2 EDGAR HTML - c100639preflight.htm As filed with the Securities and Exchange Commission on October 30, 2020 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 COLGATE-PALMOLIVE COMPANY (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorpor
October 30, 2020	EX-10.A	364-day Credit Agreement, dated as of August 21, 2020, among Colgate-Palmolive Company, as Borrower, Citibank, N.A., as Administrative Agent and Arranger, and the Lenders party thereto.* EXHIBIT 10-A EXECUTION COPY 364-DAY CREDIT AGREEMENT Dated as of August 21, 2020 Among COLGATE-PALMOLIVE COMPANY as Borrower THE BANKS NAMED HEREIN as Banks BANK OF AMERICA, N.
October 30, 2020	EX-99.1	Colgate Appoints Stanley J. Sutula as Chief Financial Officer Exhibit 99.1 Colgate Appoints Stanley J. Sutula as Chief Financial Officer Henning Jakobsen to Retire December 31, 2020 NEW YORK-(BUSINESS WIRE)-October 30, 2020-Colgate-Palmolive Company (NYSE:CL) announced today the appointment of Stanley J. Sutula, currently Executive Vice President and Chief Financial Officer of Pitney Bowes Inc., to succeed Henning Jakobsen as Chief Financial Officer, effecti
October 30, 2020	EX-99	Colgate Announces 3rd Quarter 2020 Results Exhibit 99 Colgate Announces 3rd Quarter 2020 Results NEW YORK-(BUSINESS WIRE)-October 30, 2020-Colgate-Palmolive Company (NYSE:CL) Net sales increased 5.
October 30, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - COLGATE-PALMOLIVE COMPANY 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) (October 30, 2020) COLGATE-PALMOLIVE COMPANY (Exact name of registrant as specified in its charter) Delaware 1-644 13-1815595 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.

MX:CL
DE:CPA	€ 72.54
IT:1CL	€ 72.27
GB:0P59
GB:CPAD
AT:COLG
CH:CL

CL / Colgate-Palmolive Company - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)

Other Listings